| 691 |
Candesartan cilexetil
|
-
Candesartan cilexetil, CAS-RN: 145040-37-5, DTXSID5020239
|
None
|
| 597 |
Capta
|
|
None
|
| 594 |
Captafol
|
-
Captafol, CAS-RN: 2425-06-1, DTXSID4020242
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 595 |
Captan
|
-
Captan, CAS-RN: 133-06-2, DTXSID9020243
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 92 |
Carbamazepine
|
-
Carbamazepine, CAS-RN: 298-46-4, DTXSID4022731
|
None
|
| 129 |
Carbendazim
|
-
Carbendazim, CAS-RN: 10605-21-7, DTXSID4024729
|
None
|
| 545 |
Carbenoxolone
|
-
Carbenoxolone, CAS-RN: 5697-56-3, DTXSID4022733
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 740 |
Carbon black
|
-
Carbon black, CAS-RN: 1333-86-4, DTXSID7051216
|
451: Interaction with lung resident cell membrane components leads to lung cancer
|
| 318 |
Carbon nanotubes
|
|
3 AOPs
|
| 339 |
Carbon nanotubes, Multi-walled carbon nanotubes, Single-walled carbon nanotubes, carbon fibres
|
|
None
|
| 338 |
Carbon nanotubes, Multi-walled carbon nanotubes, single-walled carbon nanotubes, carbon nanofibres
|
|
2 AOPs
|
| 13 |
Carbon tetrachloride
|
-
Carbon tetrachloride, CAS-RN: 56-23-5, DTXSID8020250
|
38: Protein Alkylation leading to Liver Fibrosis
|
| 602 |
Carbonyl cyanide m-chlorophenyl hydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 601 |
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 194 |
Carprofen
|
-
Carprofen, CAS-RN: 53716-49-7, DTXSID1045871
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|
| 622 |
cationic polyamidoamine dendrimer (nanoparticle)
|
|
319: Binding to ACE2 leading to lung fibrosis
|
| 86 |
Celecoxib
|
-
Celecoxib, CAS-RN: 169590-42-5, DTXSID0022777
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|
| 628 |
cell free mitochondrial DNA (mtDNA)
|
|
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|
| 507 |
Cetrorelix
|
-
Cetrorelix, CAS-RN: 120287-85-6, DTXSID7040996
|
309: Luteinizing hormone receptor antagonism leading to reproductive dysfunction
|
| 240 |
Chemical
|
|
205: AOP from chemical insult to cell death
|
| 439 |
Chemical:20384 Dexamethasone, minocycline, innamicaldehyde
|
|
None
|
| 630 |
Chemical:33664 17-Methyltestosterone
|
|
376: Androgen receptor agonism leading to male-biased sex ratio
|
| 355 |
Chemical:584015 (1-~13~C)Aniline
|
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 481 |
CHIR-98014
|
|
None
|
| 480 |
CHIR-99021
|
-
CHIR-99021, CAS-RN: 252917-06-9, DTXSID90179931
|
None
|